N. Reynaert (Maastricht, Netherlands), K. Bracke (Ghent, Belgium)
Immune signaling pathways and cell expression is linked to pulmonary fibrosis
M. Ali (New Delhi, India), S. Verma (Lucknow, India), A. Chopra (New Delhi, India), S. Mittal (New Delhi, India), A. Mohan (New Delhi, India), A. Bhalla (New Delhi, India), S. Arava (New Delhi, India), V. Hadda (New Delhi, India)
|  |
Genetic deletion of SLPI results in increased protease activity and mucus clearance in a murine model of chronic lung disease
P. Ferris (Belfast, United Kingdom), R. Brown (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), C. Dougan (Belfast, United Kingdom), D. Doherty (Belfast, United Kingdom), D. Small (Belfast, United Kingdom), M. Mall (Berlin, Germany), D. Mcauley (Belfast, United Kingdom), B. Connolly (Belfast, United Kingdom), S. Weldon (Belfast, United Kingdom), C. Taggart (Belfast, United Kingdom)
|  |
Deciphering the role of angiogenic T cells in the lung vasculopathy of rheumatoid arthritis, systemic sclerosis and other autoimmune diseases
V. Pulito-Cueto (Santander, Spain), S. Remuzgo-Martínez (Santander, Spain), F. Genre (Santander, Spain), B. Atienza-Mateo (Santander, Spain), V. Portilla (Santander, Spain), V. Mora-Cuesta (Santander, Spain), D. Iturbe-Fernández (Santander, Spain), L. Lera-Gómez (Santander, Spain), J. Rodriguez-Carrio (Oviedo, Spain), D. Prieto-Peña (Santander, Spain), R. Blanco (Santander, Spain), A. Corrales (Santander, Spain), O. Gualillo (Santiago de Compostela, Spain), J. Cifrián (Santander, Spain), R. López-Mejías (Santander, Spain), M. Gónzalez-Gay (Santander, Spain)
| |
Macrophages – the conductor of inflammation in COPD?
B. Jouleh (Bergen, Norway), R. Nielsen (Bergen, Norway), . Bakke (Bergen, Norway), R. Sandvik (Bergen, Norway), T. Kalananthan (Bergen, Norway), J. Ward (Southampton, United Kingdom), S. Wilson (Southampton, United Kingdom), T. Eagan (Bergen, Norway)
| |
Hypertonic saline triggers inflammatory responses in THP-1 derived macrophages
F. Sposito (Liverpool, United Kingdom), S. Northey (Liverpool, United Kingdom), P. Mcnamara (Liverpool, United Kingdom), C. Hedrich (Liverpool, United Kingdom)
| |
The role of airway neutrophils in primary ciliary dyskinesia
M. Blanter (Leuven, Belgium), M. Cockx (Leuven, Belgium), M. De Bondt (Leuven, Belgium), S. Abouelasrar Salama (Leuven, Belgium), L. Wittebols (Leuven, Belgium), L. Vanbrabant (Leuven, Belgium), N. Pörtner (Leuven, Belgium), N. Berghmans (Leuven, Belgium), N. Lorent (Leuven, Belgium), M. Boon (Leuven, Belgium), S. Struyf (Leuven, Belgium)
| |
Eosinophils sub-types differ between patients with asthma and COPD
C. Cabrera Lopez (Las Palmas de Gran Canaria, Spain), A. Sánchez Santos (Las Palmas de Gran Canaria, Spain), A. Lemes Castellano (Las Palmas de Gran Canaria, Spain), S. Cazorla Rivero (Las Palmas de Gran Canaria, Spain), J. Breña Atienza (Santa Cruz de Tenerife, Spain), E. González Dávila (Santa Cruz de Tenerife, Spain), J. De Torres Tajes (Kingston, Canada), M. Divo (Boston, United States), V. Pinto-Plata (Springfield, United States), F. Polverino (Tucson, United States), J. Marin (Zaragoza, Spain), B. Celli (Boston, United States), C. Casanova Macario (Santa Cruz de Tenerife, Spain)
| |
Innate lymphoid cells 2 (ILC2) in the transition from pediatric wheezing to asthma
M. Bonato (Padova, Italy), E. Bazzan (Padova, Italy), T. Maes (Ghent, Belgium), G. Brusselle (Ghent, Belgium), G. Turato (Padova, Italy), Y. Padrin (Padova, Italy), M. Turrin (Treviso, Italy), M. Cosio (Montreal, Canada), A. Barbato (Padova, Italy), M. Saetta (Padova, Italy), S. Baraldo (Padova, Italy)
| |
Activated type 2 innate lymphoid cells are elevated in children with uncontrolled asthma
K. Golebski (Amsterdam, Netherlands), S. Bjorkander (Stockholm, Sweden), Y. Van Dijk (Amsterdam, Netherlands), B. Gole (Maribor, Slovenia), M. Kabesch (Regensburg, Germany), A. Maitland-Van Der Zee (Amsterdam, Netherlands), E. Melén (Stockholm, Sweden), E. Van Der Ploeg (Rotterdam, Netherlands), U. Potocnik (Maribor, Slovenia), S. Reinartz (Hilversum, Netherlands), E. Santos Valente (Regensburg, Germany), R. Stadhouders (Rotterdam, Netherlands), C. Van Drunen (Amsterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands)
| |
Identification of Irf8-dependent pulmonary DC subsets using scRNASeq in experimental model of asthma and tolerance
A. Jirmo (Hannover, Germany), R. Grychtol (Hannover, Germany), S. Gaedcke (Hannover, Germany), B. Liu (Hannover, Germany), S. Destefano (Hannover, Germany), C. Happle (Hannover, Germany), O. Halle (Hannover, Germany), J. Monteiro (Hannover, Germany), O. Breiholz (Hannover, Germany), D. Deluca (Hannover, Germany), G. Hansen (Hannover, Germany)
| |
Eosinophil-epithelial respiratory cells crosstalk in IL-33 mediated inflammation 3D models.
C. Afferni (Roma (RM), Italy), A. Gambardella (Roma (RM), Italy), S. Andreone (Roma (RM), Italy), F. Mattei (Roma (RM), Italy), G. Schiavoni (Roma (RM), Italy)
| |
Visualisation of longitudinal corticosteroid-mediated changes in T2 and IL-17A-producing cell populations using multiparameter CyTOF and tSNE
G. Hynes (Oxford (Oxfordshire), United Kingdom), G. Donachie (Oxford (Oxfordshire), United Kingdom), S. Morgan (Oxford (Oxfordshire), United Kingdom), M. Downs (Oxford (Oxfordshire), United Kingdom), I. Pavord (Oxford (Oxfordshire), United Kingdom), T. Hinks (Oxford (Oxfordshire), United Kingdom)
| |
Mechanisms of nasal epithelial cell permeability in eosinophilic Severe Asthma: effect of anti-IL5R therapy
K. Raby (London, United Kingdom), P. Dixey (London, United Kingdom), N. Zounemat Kermani (London, United Kingdom), J. Koranteng (London, United Kingdom), F. Chung (London, United Kingdom), P. Bhavsar (London, United Kingdom)
| |
Effect of IL-3, IL-5 and GM-CSF on adhesion and chemotaxis of blood eosinophil subtypes in allergic asthma
A. Rimkunas (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), E. Vasyle (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
Eosinophil Subtypes Affect Airway Smooth Muscle Cells Proliferation Autocrine Adjustment via Extracellular Matrix Proteins Production in Asthma
A. Januskevicius (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), E. Jurkeviciute (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
Activation of blood eosinophil subtypes proliferative properties by eosinophilopoetins in severe non-allergic eosinophilic asthma
J. Palacionyte (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), E. Jurkeviciute (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
LSC - 2022 - Effect of eosinophilopoetins on proliferative properties of blood eosinophil subtypes in allergic asthma
J. Palacionyte (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), E. Jurkeviciute (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
The Effect of Bronchial Allergen Challenge on Blood Eosinophil Subtypes-Specific miRNAs Expression in Allergic Asthma
E. Jurkeviciute (Kaunas, Lithuania), P. Malakauskaite (Vilnius, Lithuania), A. Januskevicius (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
| |
Late Breaking Abstract - Electronic cigarette vapour suppresses human neutrophil functions and alters phenotype, irrespective of nicotine content.
A. Jasper (Birmingham, United Kingdom), A. Faniyi (Birmingham, United Kingdom), L. Davis (Birmingham, United Kingdom), F. Grudzinska (Birmingham, United Kingdom), R. Halston (Birmingham, United Kingdom), D. Parekh (Birmingham, United Kingdom), E. Sapey (Birmingham, United Kingdom), D. Thickett (Birmingham, United Kingdom), A. Scott (Birmingham, United Kingdom)
| |